Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
News
Sports
TV & Film
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/51/b1/3d/51b13d00-4422-e48c-844a-574c522e9b4d/mza_15952857728625934801.jpg/600x600bb.jpg
Personable
Harvey
105 episodes
1 week ago
In this episode of Personable Markets, host Harvey Bracken-Smith and guest Luke Sloman analyze a defining week in global finance. Nvidia hits a $5 trillion valuation, the Federal Reserve pauses rate cuts, and Trump and Xi Jinping outline a potential new trade framework that could reshape technology, agriculture, and rare-earth supply chains. They explore the AI-driven surge in earnings from major tech firms, the growing dominance of the “BATMMAAN” stocks, and the UK’s controversial tax propo...
Show more...
Entrepreneurship
Business
RSS
All content for Personable is the property of Harvey and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of Personable Markets, host Harvey Bracken-Smith and guest Luke Sloman analyze a defining week in global finance. Nvidia hits a $5 trillion valuation, the Federal Reserve pauses rate cuts, and Trump and Xi Jinping outline a potential new trade framework that could reshape technology, agriculture, and rare-earth supply chains. They explore the AI-driven surge in earnings from major tech firms, the growing dominance of the “BATMMAAN” stocks, and the UK’s controversial tax propo...
Show more...
Entrepreneurship
Business
https://storage.buzzsprout.com/klazwwgjthtyb9rj13rwzy6r1fps?.jpg
David Esposito (CEO ONL Therapeutics): Why Big Pharma MUST Take Big Risks For A Healthy Society!
Personable
1 hour 9 minutes
1 month ago
David Esposito (CEO ONL Therapeutics): Why Big Pharma MUST Take Big Risks For A Healthy Society!
David Esposito, President & CEO of ONL Therapeutics, joins Personable. From graduating West Point with a BS in Civil Engineering, to leading an infantry platoon in combat with the 101st Airborne Division, David brings a unique perspective from military service to biotech leadership. With experience spanning pharma sales at Merck, diagnostics leadership, and biotech exits (Armune BioScience to Exact Sciences, Phadia to Thermo Fisher), David has navigated high-stakes environments from batt...
Personable
In this episode of Personable Markets, host Harvey Bracken-Smith and guest Luke Sloman analyze a defining week in global finance. Nvidia hits a $5 trillion valuation, the Federal Reserve pauses rate cuts, and Trump and Xi Jinping outline a potential new trade framework that could reshape technology, agriculture, and rare-earth supply chains. They explore the AI-driven surge in earnings from major tech firms, the growing dominance of the “BATMMAAN” stocks, and the UK’s controversial tax propo...